A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer
Titel:
A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer
Auteur:
Ko, Andrew H. Venook, Alan P. Bergsland, Emily K. Kelley, R. Kate Korn, W. Michael Dito, Elizabeth Schillinger, Brian Scott, Janet Hwang, Jimmy Tempero, Margaret A.